CG
NMRD

Cutler Group’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Cutler Group’s Portfolio NMRD Stock Details NMRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,801
Closed -$27.4K – 6573
2021
Q2 		$39K Buy
+3,801
New +$36.3K ﹤0.01% 2715

Other funds holding NMRD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Cutler Group's NMRD Position: Q3 2021 in Review

Cutler Group sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q3 2021, closing a stake of 3,801 shares — an estimated $27.4K sold.

Cutler Group first reported a position in NMRD in Q2 2021 and held it in 1 quarter. The position peaked at $39K in Q2 2021. 17 funds tracked by Wall St. Rank hold NMRD as of Q3 2021.

  • Cutler Group reported no remaining Nemaura Medical, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Cutler Group sold 3,801 Nemaura Medical, Inc. Common Stock shares in Q3 2021, an estimated $27.4K.
  • Cutler Group first reported a position in Nemaura Medical, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Cutler Group's Nemaura Medical, Inc. Common Stock position peaked at $39K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q3 2021.

Based on Cutler Group's 13F filing for Q3 2021, filed 26 Oct 2021.